Chiral Technology

Published by: Global Industry Analysts

Published: Jan. 1, 2007 - 279 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Chiral Technology Enabling Products

Chiral Intermediates

Analytical Products

Other Products

Chiral Technology End-Use Products

Pharmaceuticals

Agrochemicals

II. EXECUTIVE SUMMARY

1. Introduction

An Insight into Chiral Technology

Techniques Used for Achieving Single-Isomers

Importance and Advancements

2. Global Market Overview

Outlook and Trends

Good Tidings for Chiral Technology

Market Drivers

Demand for Chiral-based Therapeutic Drugs Augments Growth

New Legislations Push Chiral Technology Demand

Key Trends

Organizations Extend Approaches

Companies’ Association with Universities

3. Chiral Technology - An Overview

Definitions

Chiral Technology Enabling Products

Chiral Intermediates

Analytical Products

Other Products

Chiral Technology End-Use Products

Pharmaceuticals

Agrochemicals

Description

Functioning of Chiral Molecules

Chiral Preparation Process

Traditional Methods

Biological Methods

Asymmetric Methods

Chiral Separation

Chromatography - The Widely Used Method for Separation

How it Works?

Chiral Mobile Phase Additive (CMPA)

Chiral Stationary Phase (CSP)

Chiral Recognition

Protein Chiral Stationary Phases

Carbohydrate Columns

Pirkle Columns

Crystallization

Solvent Extraction

Kinetic Resolution

Capillary Electrophoresis

Receptor Based Resolution

Miscellaneous Separative Techniques

Chiral Synthesis

4. Chiral Technology - Development vs. Acquisition

In-House Creation & Development

Acquisition of Technology

“Economics” of Chiral Technology

5. Chiral Analysis Products

Chiral Analytical Chromatography

Chiral Liquid Chromatography

Table 1: Non-Analytical Liquid Chromatography Demand by Industry in 2001(includes corresponding Graph/Chart)

Supercritical Fluid Chromatography - Substitute to LC for Enantiomer Separations

Chiral Gas Chromatography

Chiral Simulated Moving Bed Chromatography

Partition Chromatography

Adsorption Chromatography

Computer Assisted Resolution

Chiral Polarimetry

Other Chiral Analytical Techniques

Calorimetry

Differential Scanning Calorimetry (DSC)

Enzymatic Assay

Immunoassay

Isotope Dilution

Nuclear Magnetic Resonance (NMR)

X-Ray Crystallography

6. Application Markets

Pharmaceuticals - The Largest Market

Changing Face of the Pharmaceutical Industry

Analysis of Chiral Drugs

Select Companies Involved in Chiral Technology Market in 2000

Table 2: Single-Enantiomer Drugs Market Worldwide in 2002: Sales of Leading Brands (In US$ Millions) (includes corresponding Graph/Chart)

Table 3: Single-Enantiomer Drugs Market Worldwide in 2002: Percentage Breakdown by Therapeutic Category (includes corresponding Graph/Chart)

Drugs Built on Chiral Technology

Analgesics

Anesthetics

Anti-Infective Products

Cardiovascular System (CVS) Products

Angiotensin-Converting Enzyme (ACE) Inhibitors

Beta-Blockers

Calcium Channel Blockers

Diuretics

Vasodilators

Central Nervous System (CNS) Agents

Anticonvulsants

Sedatives and Tranquilizers

Stimulants and Antidepressants

Oncogenic (Cancer-Treatment) Products

Biochemicals

Oligonucleotides

Oxyacids

Amino Acids

Sugars and Other Oligosaccharides

Vitamins

Peptides

Pesticides - A Thriving Market

Herbicides

Insecticides

Fungicides

Other Products

Liquid Crystals

Flavor and Aroma Chemicals

7. Chiral Isomerism

Organic Chemical Isomerism Types

Structural Isomerism

Chain Isomerism

Position Isomerism

Functional Group Isomerism

Stereoisomerism

Dynamic Isomerism (Tautomerism)

Patents

Table 4: Patents Related to Chiral Technology (includes corresponding Graph/Chart)

8. Regulatory & Environmental Issues

Regulatory & Environmental Issues

9. Product Introductions

Evolved Nanomaterial Releases Revolutionary Analytical Chiral Column

BASF Develops Novel Process to Produce Chiral Intermediates

Chiral Quest Launches C3 TunePhos

Rhodia Pilot Tests Asymmetric Dihydroxylation Technology

Dowpharma Develops New Rhodium Based Catalysts

CoValence Inc uses Chiral Technology in Skin Care Products

Diversa Unveils New Nitrilase Platform, DiscoveryPoint™

Bayer Releases Chiral Ligand

Bayer Introduces New Chiral Technology

Daicel Develops Low-Cost Biotech Reduction Process

Rhodia Introduces Two Single Enantiomer Fragrances

10. Recent Industry Activity

Sigma-Aldrich Corp Acquires Astec

Solvias Receives License for MeOBIPHEP Catalyst Technology

Codexis Acquires Juelich Fine Chemicals

ChiroBlock Exits from Chiral Compounds Business

Chiral Quest Opens New Facility in China

Chiral Quest to Supply C3 TunePhos to Phoenix Chemicals

Lonza and Codexis Sign Agreement for Biocatalysis Process

DSM Signs Licensing Agreement with Chiral Quest

Chiral Quest Signs Distribution Agreement with Aldrich Chemical

BASF and Solvias to Collaborate on Chiral Molecule Development

Chiral Chemistry Technology to be Introduced in Europe

Chiral Quest and Avantium Enter into Partnership

Chiral Quest Opens New Laboratory in New Jersey

Eastman Chemical and Johnson Matthey sign Marketing Agreement

Daiso signs Strategic Agreement with Brandeis University

Dowpharma Extends Licensing Agreement with JST

SUVEN Life Sciences Acquires Synthon Chiragenics Corp

Avecia Acquires “Chiral Technologies” from Synthon Chiragenics

Chiral Quest & Surg II Consummate Deal

Johnson Matthey in Partnership with Seton Hall University

Chirotech and Acros Organics Sign Marketing Agreement

Synetix Licenses Technology from Merck

Synetix Signs Licensing Agreement with Yale University

Clariant Pharmaceuticals Signs Agreement with Chiral Quest

Synetix Licenses-in 3 Families of Chiral Ligands

OMG and Solvias Join Hands for Developing Chiral Catalysts

Synetix Chiral Technologies Signs Agreement with Avecia Pharmaceuticals

Synetix Starts a Chiral Catalyst Laboratory

Dow UK Acquires Ascot

Degussa Acquires Aventis Research & Technologies

Ricerca LLC Forges Alliance with Chemi SPA

Chirotech Licenses Asymmetric Hydrogenation of Ketones Technology

Degussa AG Signs R&D Agreement with Medichem Life Sciences

Onyx Scientific Inks Distribution Agreement with Aldrich Chemical

Rhodia Chirex and Aldrich Chemical Enter into Agreement

Synetix and Rhodia ChiRex in Joint Agreement

Chiral Technologies Introduces VeloCT-CSP

Dow Chemicals and Diversa Expand Cooperation

Synthon Chiragenics to Incorporate Carbohydrate- Based Therapeutics

Ind Swift Labs Initiates Production at its New Drug Manufacturing Facility

Onyx Scientific Wins Exclusive License from University of Durham

Albright & Wilson Signs Five-Year Supply Contract with ChiroTech

Cambrex Signs Agreement with Synthon Chiragenics

Dow Chemical and Diversa Enter into an Agreement

BASF Opens New Chiral Amines Facility

11. Focus on Select Players

Albemarle Corporation (USA)

BASF AG (Germany)

Cambrex Corp. (USA)

Chiral Quest Inc (US)

Chirotech Technology Ltd. (UK)

Dalco ChromTech AB (Sweden)

Daicel Chemical Industries Ltd. (Japan)

DSM Pharmaceutical Products (Netherlands)

Johnson Matthey PLC (UK)

Regis Technologies Inc (USA)

Rhodia Pharma Solutions (USA)

Solvias (Switzerland)

Sigma Aldrich Corp (USA)

Suven Life Sciences Ltd. (USA)

12. Global Market Perspective

Table 5: World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 6: World 10-Year Perspective for Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 7: World Recent Past, Current & Future Analysis for Chiral Intermediates by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 8: World 10-Year Perspective for Chiral Intermediates by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 9: World Recent Past, Current & Future Analysis for Chiral Analytical Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 10: World 10-Year Perspective for Chiral Analytical Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 11: World Recent Past, Current & Future Analysis for Other Chiral Technology Enabling Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 12: World 10-Year Perspective for Other Chiral Technology Enabling Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 13: World Recent Past, Current & Future Analysis of Chiral End-Use Products by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 14: World 10-Year Perspective of Chiral End-Use Products by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 15: World Recent Past, Current & Future Analysis for Chiral Technology in Pharmaceuticals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 16: World 10-Year Perspective for Chiral Technology in Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 17: World Recent Past, Current & Future Analysis for Chiral Technology in Agrochemicals by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 18: World 10-Year Perspective for Chiral Technology in Agrochemicals by Geographic Region - Percentage Breakdown of Value Sales for US, Japan, Europe, and Rest of World Markets for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Overview

Product Introductions/Developments

Strategic Developments

Key Players

B. Market Analytics

Table 19: US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 20: US 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Segments for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 21: US Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by End-Use Segment - Pharmaceutical, and Agrochemical Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 22: US 10-Year Perspective for Chiral Technology Enabling Products by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceutical, and Agrochemical Segments for the Years 2000, 2006 & 2010

2. Japan

A. Market Analysis

Outlook

Product Introduction (Historic)

Key Player

B. Market Analytics

Table 23: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 24: Japanese 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Segments for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 25: Japanese Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by End-Use Segment - Pharmaceutical, and Agrochemical Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 26: Japanese 10-Year Perspective for Chiral Technology Enabling Products by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceutical, and Agrochemical Segments for the Years 2000, 2006 & 2010

3. Europe

A. Market Analysis

Overview

Product Introductions

Strategic Developments

Key Players

B. Market Analytics

Table 27: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 28: European 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Segments for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 29: European Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by End-Use Segment - Pharmaceutical, and Agrochemical Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 30: European 10-Year Perspective for Chiral Technology Enabling Products by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceutical, and Agrochemical Segments for the Years 2000, 2006 & 2010

4. Rest of World

A. Market Analysis

Outlook

India

Chiral Drugs in Indian Market

China-A Hub for Pharmaceutical Manufacturing

B. Market Analytics

Table 31: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by Product Segment - Intermediates, Analytical, and Other Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 32: Rest of World 10-Year Perspective for Chiral Technology Enabling Products by Product Segment - Percentage Breakdown of Value Sales for Intermediates, Analytical, and Other Segments for the Years 2000, 2006 & 2010 (includes corresponding Graph/Chart)

Table 33: Rest of World Recent Past, Current & Future Analysis for Chiral Technology Enabling Products by End-Use Segment - Pharmaceutical, and Agrochemical Segments Independently Analyzed by Annual Sales for the Years 2000 through 2010 in US$ Million (includes corresponding Graph/Chart)

Table 34: Rest of World 10-Year Perspective for Chiral Technology Enabling Products by End-Use Segment - Percentage Breakdown of Value Sales for Pharmaceutical, and Agrochemical Segments for the Years 2000, 2006 & 2010

IV. COMPETITION

1. Advanced Asymmetrics, Inc. (USA)

2. Aims Fine Chemical, Inc. (Canada)

3. Albany Molecular Research, Inc. (USA)

Table 35: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 36: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 37: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 38: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

4. Albemarle Corporation (USA)

Table 39: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 40: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 41: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 42: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 43: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

5. Alltech Associates, Inc. (USA)

6. Ampac Fine Chemicals (USA)

7. Avecia Limited (UK)

Avecia, Inc. (USA)

8. BASF AG (Germany)

Table 44: First Quarter Sales Analysis: 2005-2006 (In € billion)

Table 45: First Quarter Sales Analysis by Segment: 2005-2006 (In € billion)

Table 46: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In € billion)

Table 47: Annual Sales Analysis: 2004-2005 (In € billion)

BASF Corporation (USA)

9. Cambrex Corporation (USA)

Table 48: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 49: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 50: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 51: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

10. Chemi SpA (Italy)

11. Chiral Quest, Inc. (USA)

12. Chiralizer Services LLC (USA)

13. Codexis, Inc. (USA)

14. Daicel Chemical Industries Ltd. (Japan)

Table 52: Annual Sales Analysis: 2005-2006 (In ¥ million)

Table 53: Annual Sales Analysis by Product Segment: 2005-2006 (In ¥ million)

Table 54: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ million)

Table 55: Annual Sales Analysis: 2004-2005 (In ¥ million)

Table 56: Annual Sales Analysis by Product Segment: 2004-2005 (In ¥ million)

Table 57: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million)

Daicel (U.S.A), Inc. (USA)

Chiral Technologies Europe Sarl (France)

Chiral Technologies, Inc. (USA)

15. Daiso Co., Ltd. (Japan)

16. Dalco ChromTech AB (Sweden)

17. Degussa Corporation (USA)

18. Diversa Corporation (USA)

Table 58: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 59: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 60: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 61: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 62: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 63: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

19. Dowpharma (USA)

Chirotech Technology Limited (UK)

20. DSM Pharmaceutical Products (The Netherlands)

DSM Fine Chemicals, Inc. (USA)

21. Eastman Chemical Company (USA)

Table 64: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 65: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 66: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 67: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 68: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 69: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 70: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 71: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

22. Evolved Nanomaterial Sciences, Inc. (USA)

23. Genzyme Corporation (USA)

Table 72: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 73: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 74: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 75: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 76: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 77: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 78: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion)

24. IEP GmbH (Germany)

25. Johnson Matthey PLC (UK)

Table 79: Annual Sales Analysis: 2004-2006 (In £ billion)

Table 80: Annual Sales Analysis by Segment: 2005-2006 (In £ billion)

Table 81: Annual Sales Analysis by Geographic Region: 2005-2006 (In £ billion)

Table 82: Annual Sales Analysis by Segment: 2004-2005 (In £ billion)

Table 83: Annual Sales Analysis by Geographic Region: 2004-2005 (In £ billion)

Johnson Matthey Catalysts & Chemicals (USA)

26. Lonza Group Ltd. (Switzerland)

Table 84: Annual Sales Analysis: 2004-2005 (In CHF million)

Table 85: Annual Sales Analysis by Segment: 2004-2005 (In CHF million)

Table 86: Annual Sales Analysis by Geographic Region: 2004-2005 (In CHF million)

27. Novasep SAS (France)

28. Phenomenex, Inc. (USA)

29. Polium Technologies, Inc. (USA)

30. PPG - Sipsy (France)

31. Purac America (USA)

32. Regis Technologies, Inc. (USA)

33. Rhodia SA (France)

Table 87: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In € million)

Table 88: Annual Sales Analysis: 2004-2005 (In € million)

Table 89: Quarterly Sales Analysis: 2004-2005 (In € million)

34. Sepracor, Inc. (USA)

Table 90: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 91: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

35. Sichuan Guanghan Bio-Tech Co., Ltd. (China)

36. Sigma-Aldrich Corporation (USA)

Table 92: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 93: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 94: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 95: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 96: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 97: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 98: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Advanced Separation Technologies, Inc. (USA)

37. Solvias AG (Switzerland)

38. Strem Chemicals, Inc. (USA)

39. Suven Life Sciences Ltd. (India)

Table 99: First Quarter Sales Analysis: 2006-2007 (Q1) (In INR million)

Table 100: Annual Sales Analysis: 2004-2006 (In INR million)

Table 101: Annual Sales Analysis by Segment: 2005-2006 (In INR million)

Table 102: Annual Sales Analysis by Geographic Region: 2005-2006 (In INR million)

Table 103: Annual Sales Analysis by Geographic Region: 2004-2005 (In INR million)

Suven Life Sciences Ltd. (USA)

40. Synthetech, Inc. (USA)

Table 104: Half Yearly Sales Analysis: 2006-2007 (H1) (In US$ million)

Table 105: Half Yearly Sales Analysis by Quarter: 2006-2007 (H1) (In US$ million)

Table 106: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 107: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 108: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Table 109: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Abstract

This report analyzes the worldwide markets for Chiral Technology in US$ Million. Chiral Technology Enabling Products analyzed are Intermediates, Analytical, and Others. The specific end-use segments discussed are Pharmaceuticals, and Agrochemicals. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 40 companies including many key and niche players worldwide such as Albemarle Corporation, BASF AG, Cambrex Corp., Chiral Quest Inc., Chirotech Technology Ltd., Dalco ChromTech AB, Daicel Chemical Industries Ltd., DSM Pharmaceutical Products, Johnson Matthey PLC, Regis Technologies Inc., Rhodia Pharma Solutions, Solvias, Sigma Aldrich Corp, and Suven Life Sciences Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies (when hard copy is available)is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.